FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094641572> ?p ?o ?g. }

• W3094641572 abstract "Abstract This study was performed to evaluate the long-term cardiovascular safety of gemigliptin in patients with type 2 diabetes mellitus (T2DM). After screening, eligible patients with T2DM were enrolled, received gemigliptin, and were followed up for a median of 2.50 years. The primary outcome was a composite of confirmed cardiovascular death, nonfatal myocardial infarction, or nonfatal ischemic stroke (3-point major adverse cardiovascular event [MACE]). The key secondary outcomes were incidence of all-cause mortality and any other cardiovascular events. A total of 5179 patients were included in the study and 5113 were treated with gemigliptin. Overall, the primary outcome occurred in 26 patients within 12 months (estimated incidence by Cox proportional hazard model 0.49%, 95% CI 0.29–0.69%) and in 54 patients within 54 months (estimated incidence from Cox proportional hazard model 1.35%, 95% CI 0.92–1.77%). During the study period, the incidence rates of each component of the primary composite outcome were 0.04% (0.2 events per 1000 person-years) for cardiovascular death, 0.51% (2.2 events per 1000 person-years) for nonfatal myocardial infarction, and 0.61% (2.5 events per 1000 person-years) for nonfatal ischemic stroke. The incidence of all-cause mortality was 0.82% (3.2 events per 1000 person-years) and the incidences of other cardiovascular events were all less than 0.3%. In conclusion, T2DM patients who received gemigliptin exhibited a low incidence of the primary composite MACE and all-cause mortality. Therefore, the use of gemigliptin is expected to be safe without an increase in cardiovascular risk. Trial registration: The study was registered at ClinicalTrials.gov (identifier: NCT02290301)." @default.
• W3094641572 created "2020-11-09" @default.
• W3094641572 creator A5007954531 @default.
• W3094641572 creator A5034050916 @default.
• W3094641572 creator A5036240200 @default.
• W3094641572 creator A5041198204 @default.
• W3094641572 creator A5053791153 @default.
• W3094641572 creator A5079693740 @default.
• W3094641572 creator A5086495025 @default.
• W3094641572 creator A5087387214 @default.
• W3094641572 creator A5087426380 @default.
• W3094641572 creator A5088812559 @default.
• W3094641572 date "2020-11-04" @default.
• W3094641572 modified "2023-09-23" @default.
• W3094641572 title "A prospective cohort study on effects of gemigliptin on cardiovascular outcomes in patients with type 2 diabetes (OPTIMUS study)" @default.
• W3094641572 cites W1914121615 @default.
• W3094641572 cites W1932640386 @default.
• W3094641572 cites W1968850615 @default.
• W3094641572 cites W1973037639 @default.
• W3094641572 cites W2016298811 @default.
• W3094641572 cites W2064130493 @default.
• W3094641572 cites W2069483325 @default.
• W3094641572 cites W2098130207 @default.
• W3094641572 cites W2114349038 @default.
• W3094641572 cites W2118812428 @default.
• W3094641572 cites W2123946565 @default.
• W3094641572 cites W2127854619 @default.
• W3094641572 cites W2131821161 @default.
• W3094641572 cites W2142830692 @default.
• W3094641572 cites W2143847100 @default.
• W3094641572 cites W2148092884 @default.
• W3094641572 cites W2170003639 @default.
• W3094641572 cites W2340143475 @default.
• W3094641572 cites W2409008856 @default.
• W3094641572 cites W2467143170 @default.
• W3094641572 cites W2561612220 @default.
• W3094641572 cites W2616715650 @default.
• W3094641572 cites W2638775180 @default.
• W3094641572 cites W2729516458 @default.
• W3094641572 cites W2767408736 @default.
• W3094641572 cites W2790045825 @default.
• W3094641572 cites W2891246620 @default.
• W3094641572 cites W2894993577 @default.
• W3094641572 cites W2900149048 @default.
• W3094641572 cites W2969746584 @default.
• W3094641572 doi "https://doi.org/10.1038/s41598-020-75594-5" @default.
• W3094641572 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7642439" @default.
• W3094641572 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33149182" @default.
• W3094641572 hasPublicationYear "2020" @default.
• W3094641572 type Work @default.
• W3094641572 sameAs 3094641572 @default.
• W3094641572 citedByCount "0" @default.
• W3094641572 crossrefType "journal-article" @default.
• W3094641572 hasAuthorship W3094641572A5007954531 @default.
• W3094641572 hasAuthorship W3094641572A5034050916 @default.
• W3094641572 hasAuthorship W3094641572A5036240200 @default.
• W3094641572 hasAuthorship W3094641572A5041198204 @default.
• W3094641572 hasAuthorship W3094641572A5053791153 @default.
• W3094641572 hasAuthorship W3094641572A5079693740 @default.
• W3094641572 hasAuthorship W3094641572A5086495025 @default.
• W3094641572 hasAuthorship W3094641572A5087387214 @default.
• W3094641572 hasAuthorship W3094641572A5087426380 @default.
• W3094641572 hasAuthorship W3094641572A5088812559 @default.
• W3094641572 hasBestOaLocation W30946415721 @default.
• W3094641572 hasConcept C120665830 @default.
• W3094641572 hasConcept C121332964 @default.
• W3094641572 hasConcept C126322002 @default.
• W3094641572 hasConcept C127413603 @default.
• W3094641572 hasConcept C134018914 @default.
• W3094641572 hasConcept C188816634 @default.
• W3094641572 hasConcept C201903717 @default.
• W3094641572 hasConcept C207103383 @default.
• W3094641572 hasConcept C2777180221 @default.
• W3094641572 hasConcept C2780400711 @default.
• W3094641572 hasConcept C2780645631 @default.
• W3094641572 hasConcept C2780739214 @default.
• W3094641572 hasConcept C2910068830 @default.
• W3094641572 hasConcept C44249647 @default.
• W3094641572 hasConcept C500558357 @default.
• W3094641572 hasConcept C50382708 @default.
• W3094641572 hasConcept C555293320 @default.
• W3094641572 hasConcept C61511704 @default.
• W3094641572 hasConcept C71924100 @default.
• W3094641572 hasConcept C72563966 @default.
• W3094641572 hasConcept C78519656 @default.
• W3094641572 hasConcept C88879693 @default.
• W3094641572 hasConceptScore W3094641572C120665830 @default.
• W3094641572 hasConceptScore W3094641572C121332964 @default.
• W3094641572 hasConceptScore W3094641572C126322002 @default.
• W3094641572 hasConceptScore W3094641572C127413603 @default.
• W3094641572 hasConceptScore W3094641572C134018914 @default.
• W3094641572 hasConceptScore W3094641572C188816634 @default.
• W3094641572 hasConceptScore W3094641572C201903717 @default.
• W3094641572 hasConceptScore W3094641572C207103383 @default.
• W3094641572 hasConceptScore W3094641572C2777180221 @default.
• W3094641572 hasConceptScore W3094641572C2780400711 @default.
• W3094641572 hasConceptScore W3094641572C2780645631 @default.
• W3094641572 hasConceptScore W3094641572C2780739214 @default.
• W3094641572 hasConceptScore W3094641572C2910068830 @default.
• W3094641572 hasConceptScore W3094641572C44249647 @default.

• next